MedCap AB (publ)
STO:MCAP

Watchlist Manager
MedCap AB (publ) Logo
MedCap AB (publ)
STO:MCAP
Watchlist
Price: 563 SEK 3.68% Market Closed
Market Cap: 8.3B SEK
Have any thoughts about
MedCap AB (publ)?
Write Note

MedCap AB (publ)
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MedCap AB (publ)
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
MedCap AB (publ)
STO:MCAP
Free Cash Flow
kr250.5m
CAGR 3-Years
48%
CAGR 5-Years
26%
CAGR 10-Years
31%
AddLife AB
STO:ALIF B
Free Cash Flow
kr465m
CAGR 3-Years
-18%
CAGR 5-Years
29%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Free Cash Flow
-kr112.8m
CAGR 3-Years
19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Free Cash Flow
kr243m
CAGR 3-Years
-4%
CAGR 5-Years
11%
CAGR 10-Years
20%
G
Genovis AB
STO:GENO
Free Cash Flow
kr37.3m
CAGR 3-Years
73%
CAGR 5-Years
60%
CAGR 10-Years
N/A
M
Magle Chemoswed Holding AB
STO:MAGLE
Free Cash Flow
kr209k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

MedCap AB (publ)
Glance View

Market Cap
8.3B SEK
Industry
Life Sciences Tools & Services

MedCap AB is an investment company engaged in biotechnology and medical technology capital investments. The company is headquartered in Solna, Stockholm. The company went IPO on 2006-07-04. The firm reports four segments: Abilia, Unimedic, Quickels and Inpac. The Company’s portfolio includes such companies as Abilia AB, which is engaged in the development and marketing of aids within the fields of communication, cognition, noise and environmental control; Unimedic AB, engaged in contract manufacturing of liquid pharmaceuticals; Quickels Systems AB, which is engaged in the development and marketing of intensive medical care equipment, such as care bags and electrocardiogram (ECG) equipment; AirContainer Package System AB that offers a wide range of packaging solutions for the pharmaceutical industry, and Dunmedic AB, which offers medical products, medicines and food supplements.

MCAP Intrinsic Value
423.54 SEK
Overvaluation 25%
Intrinsic Value
Price

See Also

What is MedCap AB (publ)'s Free Cash Flow?
Free Cash Flow
250.5m SEK

Based on the financial report for Sep 30, 2024, MedCap AB (publ)'s Free Cash Flow amounts to 250.5m SEK.

What is MedCap AB (publ)'s Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
31%

Over the last year, the Free Cash Flow growth was 226%. The average annual Free Cash Flow growth rates for MedCap AB (publ) have been 48% over the past three years , 26% over the past five years , and 31% over the past ten years .

Back to Top